Moderna to Host Investor Event - R&D Day and Business Updates
Moderna (Nasdaq: MRNA) has announced an upcoming Investor Event - R&D Day and Business Updates scheduled for September 12, 2024 at 9:00 a.m. ET. This event will feature presentations from the company's management team, focusing on Moderna's development and commercial strategy, as well as key business considerations.
Investors and interested parties can access a live webcast of the presentation through the 'Events and Presentations' section of Moderna's investor relations website. For those unable to attend the live event, a replay of the webcast will be available on the company's website for at least 30 days following the presentation, ensuring widespread access to this important corporate update.
Moderna (Nasdaq: MRNA) ha annunciato un prossimo Evento per gli Investitori - Giornata R&D e Aggiornamenti Aziendali previsto per il 12 settembre 2024 alle 9:00 a.m. ET. Questo evento presenterà interventi del team di gestione dell'azienda, con un focus sulla strategia di sviluppo e commerciale di Moderna, oltre a considerazioni aziendali chiave.
Investitori e parti interessate possono accedere a un webcast in diretta della presentazione tramite la sezione 'Eventi e Presentazioni' del sito web delle relazioni con gli investitori di Moderna. Per coloro che non possono partecipare all'evento in diretta, una registrazione del webcast sarà disponibile sul sito dell'azienda per almeno 30 giorni dopo la presentazione, garantendo così un accesso ampio a questo importante aggiornamento aziendale.
Moderna (Nasdaq: MRNA) ha anunciado un próximo Evento para Inversores - Día de I+D y Actualizaciones Empresariales programado para el 12 de septiembre de 2024 a las 9:00 a.m. ET. Este evento contará con presentaciones del equipo directivo de la empresa, centradas en la estrategia de desarrollo y comercial de Moderna, así como en consideraciones empresariales clave.
Los inversores y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección 'Eventos y Presentaciones' del sitio web de relaciones con inversores de Moderna. Para aquellos que no puedan asistir al evento en vivo, una repetición de la transmisión estará disponible en el sitio web de la empresa durante al menos 30 días después de la presentación, asegurando un amplio acceso a esta importante actualización corporativa.
모더나 (Nasdaq: MRNA)는 투자자 행사 - R&D의 날 및 사업 업데이트가 2024년 9월 12일 오전 9시(ET)에 예정되어 있다고 발표했습니다. 이번 이벤트에서는 회사 경영진의 발표가 진행되며, 모더나의 개발 및 상업 전략과 주요 사업 고려 사항에 중점을 둡니다.
투자자와 관심 있는 사람들은 모더나의 투자자 관계 웹사이트의 '이벤트 및 발표' 섹션을 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들은 발표 이후 최소 30일 동안 회사 웹사이트에서 재생될 웹캐스트를 이용할 수 있어, 이 중요한 회사 업데이트에 대한 광범위한 접근이 보장됩니다.
Moderna (Nasdaq: MRNA) a annoncé un prochain Événement pour les Investisseurs - Journée R&D et Mises à jour Commerciales prévu pour le 12 septembre 2024 à 9h00 (ET). Cet événement comportera des présentations de l'équipe de direction de l'entreprise, axées sur la stratégie de développement et commerciale de Moderna, ainsi que sur les considérations commerciales clés.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section 'Événements et Présentations' du site Web des relations avec les investisseurs de Moderna. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion du webinaire sera disponible sur le site de l'entreprise pendant au moins 30 jours après la présentation, garantissant ainsi un accès large à cette mise à jour d'entreprise importante.
Moderna (Nasdaq: MRNA) hat ein bevorstehendes Investoren-Event - F&E-Tag und Unternehmensaktualisierungen angekündigt, das für den 12. September 2024 um 9:00 Uhr ET geplant ist. Diese Veranstaltung wird Präsentationen des Managementteams des Unternehmens umfassen, die sich auf Modernas Entwicklungs- und Geschäftsstrategie sowie auf wichtige geschäftliche Überlegungen konzentrieren.
Investoren und interessierte Parteien können über den Bereich 'Veranstaltungen und Präsentationen' auf der Investor-Relations-Website von Moderna auf einen Live-Webcast der Präsentation zugreifen. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, wird eine Wiederholung des Webcasts für mindestens 30 Tage nach der Präsentation auf der Website des Unternehmens verfügbar sein, um einen breiten Zugang zu diesem wichtigen Unternehmensupdate zu gewährleisten.
- None.
- None.
CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 9:00 a.m. ET on Thursday, September 12, 2024.
The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations. A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on accesswire.com
FAQ
When is Moderna's Investor Event - R&D Day scheduled for 2024?
What topics will be covered during Moderna's (MRNA) 2024 Investor Event?
How can investors access Moderna's (MRNA) 2024 R&D Day presentation?
Will there be a replay available for Moderna's (MRNA) 2024 Investor Event?
